Q9NHC3
Gene name |
ced-2 (Y41D4B.13) |
Protein name |
Cell death abnormality protein 2 |
Names |
Cell-corpse engulfment protein CED-2 |
Species |
Caenorhabditis elegans |
KEGG Pathway |
cel:CELE_Y41D4B.13 |
EC number |
|
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
119-173 (N-terminal Src Homology 3 domain of Ct10 Regulator of Kinase adaptor proteins) |
Relief mechanism |
PTM |
Assay |
|
Accessory elements
No accessory elements
References
- Kobashigawa Y et al. (2007) "Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK", Nature structural & molecular biology, 14, 503-10
- Ogawa S et al. (1994) "The C-terminal SH3 domain of the mouse c-Crk protein negatively regulates tyrosine-phosphorylation of Crk associated p130 in rat 3Y1 cells", Oncogene, 9, 1669-78
- Sriram G et al. (2012) "Commentary: The carboxyl-terminal Crk SH3 domain: Regulatory strategies and new perspectives", FEBS letters, 586, 2615-8
Autoinhibited structure

Activated structure

3 structures for Q9NHC3
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
3QWX | X-ray | 201 A | X | 1-174 | PDB |
3QWY | X-ray | 252 A | A/B | 1-279 | PDB |
AF-Q9NHC3-F1 | Predicted | AlphaFoldDB |
No variants for Q9NHC3
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
No variants for Q9NHC3 |
No associated diseases with Q9NHC3
1 GO annotations of cellular component
Name | Definition |
---|---|
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
3 GO annotations of molecular function
Name | Definition |
---|---|
protein-containing complex binding | Binding to a macromolecular complex. |
receptor tyrosine kinase binding | Binding to a receptor that possesses protein tyrosine kinase activity. |
signaling adaptor activity | The binding activity of a molecule that brings together two or more molecules in a signaling pathway, permitting those molecules to function in a coordinated way. Adaptor molecules themselves do not have catalytic activity. |
9 GO annotations of biological process
Name | Definition |
---|---|
actin cytoskeleton organization | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins. |
apoptotic process | A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. |
apoptotic process involved in development | Any apoptotic process that is involved in anatomical structure development. |
cell migration | The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. |
engulfment of apoptotic cell | The removal of the apoptotic cell by phagocytosis, by a neighboring cell or by a phagocyte. |
positive regulation of distal tip cell migration | Any process that activates or increases the frequency, rate or extent of distal tip cell migration. |
positive regulation of engulfment of apoptotic cell | Any process that activates or increases the frequency, rate or extent of engulfment of apoptotic cell. |
programmed cell death | A process which begins when a cell receives an internal or external signal and activates a series of biochemical events (signaling pathway). The process ends with the death of the cell. |
signal transduction | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
8 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q04929 | CRK | Adapter molecule crk | Gallus gallus (Chicken) | SS |
Q9XYM0 | Crk | Adapter molecule Crk | Drosophila melanogaster (Fruit fly) | SS |
P46109 | CRKL | Crk-like protein | Homo sapiens (Human) | SS |
P46108 | CRK | Adapter molecule crk | Homo sapiens (Human) | EV |
P47941 | Crkl | Crk-like protein | Mus musculus (Mouse) | SS |
Q64010 | Crk | Adapter molecule crk | Mus musculus (Mouse) | EV SS |
Q5U2U2 | Crkl | Crk-like protein | Rattus norvegicus (Rat) | SS |
Q63768 | Crk | Adapter molecule crk | Rattus norvegicus (Rat) | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MTTNGFDPFE | WRSFYFPGMS | REEAHKLLGE | PQVSIGTFLM | RDSSRPGEYS | LTVREADEGN |
70 | 80 | 90 | 100 | 110 | 120 |
AVCHYLIERG | EPKEDGTAAA | GVKIANQSFP | DIPALLNHFK | MRVLTEASLL | AAYKKPIIEV |
130 | 140 | 150 | 160 | 170 | 180 |
VVGTFKFTGE | RETDLPFEQG | ERLEILSKTN | QDWWEARNAL | GTTGLVPANY | VQIQMEFHND |
190 | 200 | 210 | 220 | 230 | 240 |
RTSKGASQSS | IGSSGGGAER | FSSASTSSDN | IELQPRLPAK | AKVTFDRVPN | AYDPTQLRVK |
250 | 260 | 270 | |||
KGQTVLVTQK | MSNGMYKAEL | DGQIGSVPHT | YLRFTAVSE |